Evidence map›Paper›PMID 22925075›Full record

ReviewExpert opinion on therapeutic targets2012

ROCKs as immunomodulators of stroke.

Qing Mei Wang, James K Liao

Abstract readReview
In one paragraph

Review in Expert opinion on therapeutic targets, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. HMolecular neurobiology · 2023
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. ROCK inhibition with fasudil promotes early functional recovery of spinal cord injury in rats by enhancing microglia phagocytosis.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2016
    Article
  9. Article
  10. Selective ROCK2 Inhibition In Focal Cerebral Ischemia.Annals of clinical and translational neurology · 2014
    Article
  11. Review
  12. Metabolic actions of Rho-kinase in periphery and brain.Trends in endocrinology and metabolism: TEM · 2013
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Qing Mei WangSpaulding Rehabilitation Hospital, Department of Physical Medicine and Rehabilitation, Boston, MA, USA.
James K Liao
Brigham and Women's Hospital · USSpaulding Rehabilitation Hospital · US

Funding

LIPOPROTEINS EFFECTS ON G PROTEIN FUNCTIONR01HL052233 · NHLBI · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 1995 to 2016
$5.3M
Novel Signaling Pathways in Ischemic StrokeR01NS070001 · NINDS · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 2010 to 2014
$1.8M
ROCK and ObesityR01DK085006 · NIDDK · UNIVERSITY OF CHICAGO · PI LIAO, JAMES KUANG-JAN · 2010 to 2014
$1.7M
Role of protein kinase Akt in cerebral ischemiaP01NS010828 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI MOSKOWITZ, MICHAEL A. · 1989 to 2008
$1.4M
NHLBI NIH HHS HL052233NHLBI NIH HHS R01 HL052233NIDDK NIH HHS R01 DK085006NINDS NIH HHS NS070001NINDS NIH HHS P01 NS010828NINDS NIH HHS R01 NS070001
6 · The paper itself

Abstract

introductionStroke is the third leading cause of death and a major cause of long-term disability in the adult population. Growing evidence suggests that inflammation may play an important role in the evolution of stroke. Because Rho-associated coiled-coil containing kinases (ROCKs) are important mediators of inflammation, they may contribute to stroke and stroke recovery. AREAS COVERED: The pathophysiological role of ROCKs in mediating inflammation at different phases of stroke, and the therapeutic opportunities for stroke prevention and stroke treatment with ROCK inhibitors will be discussed. EXPERT OPINION: Inflammation is a double-edged sword during the evolution of stroke. Immunomodulation might provide a novel therapeutic approach for stroke prevention and stroke treatment. ROCK plays an important role in mediating the inflammatory response following vascular injury as well as platelet activation and thrombus formation. ROCK inhibitors have been shown to be beneficial in stroke prevention, acute neuroprotection and chronic stroke recovery by affecting inflammatory-mediated platelet and endothelial function, smooth muscle contraction and neuronal regeneration. Thus, ROCK-mediated inflammation could be a potential therapeutic target for stroke prevention and stroke treatment. However, the mechanism by which ROCKs regulate the inflammatory response is unclear, and the role of the two ROCK isoforms in stroke and stroke recovery remains to be determined.

Indexed as

AnimalsHumansImmunologic FactorsInflammationInflammation Mediatorsrho-Associated KinasesStrokeT-LymphocytesImmunologic FactorsInflammation Mediatorsrho-Associated Kinases

Identifiers

PMID22925075
PMCPMC3807092
OpenAlexW2095155444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.